NL7302728A - - Google Patents

Info

Publication number
NL7302728A
NL7302728A NL7302728A NL7302728A NL7302728A NL 7302728 A NL7302728 A NL 7302728A NL 7302728 A NL7302728 A NL 7302728A NL 7302728 A NL7302728 A NL 7302728A NL 7302728 A NL7302728 A NL 7302728A
Authority
NL
Netherlands
Application number
NL7302728A
Other versions
NL176746B (nl
NL176746C (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7302728A publication Critical patent/NL7302728A/xx
Publication of NL176746B publication Critical patent/NL176746B/xx
Application granted granted Critical
Publication of NL176746C publication Critical patent/NL176746C/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/101,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NLAANVRAGE7302728,A 1972-03-06 1973-02-27 Werkwijze voor het bereiden van farmaceutische preparaten met antihypertensieve werking, alsmede voortbrengselen verkregen door toepassing hiervan. NL176746C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00232294A US3833727A (en) 1972-03-06 1972-03-06 Hydralazine and beta-adrenergic blocking agent compositions for treating hypertension

Publications (3)

Publication Number Publication Date
NL7302728A true NL7302728A (sv) 1973-09-10
NL176746B NL176746B (nl) 1985-01-02
NL176746C NL176746C (nl) 1985-06-03

Family

ID=22872572

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7302728,A NL176746C (nl) 1972-03-06 1973-02-27 Werkwijze voor het bereiden van farmaceutische preparaten met antihypertensieve werking, alsmede voortbrengselen verkregen door toepassing hiervan.

Country Status (19)

Country Link
US (1) US3833727A (sv)
AT (1) AT331966B (sv)
BE (1) BE796288A (sv)
CA (1) CA1015662A (sv)
CY (1) CY951A (sv)
DD (1) DD103559A5 (sv)
FR (1) FR2181786B1 (sv)
GB (1) GB1385648A (sv)
HK (1) HK23378A (sv)
HU (1) HU165714B (sv)
IE (1) IE37326B1 (sv)
IL (1) IL41610A (sv)
KE (1) KE2839A (sv)
LU (1) LU67144A1 (sv)
MY (1) MY7800295A (sv)
NL (1) NL176746C (sv)
PH (1) PH18901A (sv)
SE (1) SE400472B (sv)
ZA (1) ZA731505B (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001421A (en) * 1971-10-27 1977-01-04 Syntex (U.S.A.) Inc. Thiazole cardiovascular agents
AU540656B2 (en) * 1980-02-19 1984-11-29 Merck & Co., Inc. S-(-)-1-(tert-butylamino-3((4-morpholino-1,2,5-thiadiazol-3- yl)-oxy)-2-propanol pamoate
US4521414A (en) * 1981-06-18 1985-06-04 The Texas A&M University System Ophthalmic compositions and their use for treating elevated intraocular pressure and glaucoma
US20110092507A1 (en) * 2009-10-20 2011-04-21 Chin-Tsai Fan Process for preparing R-(+)-3-morpholino-4-(3- tert-butylamino-2-hydroxypropoxy)-1,2,5-thiadiazole

Also Published As

Publication number Publication date
AT331966B (de) 1976-09-10
US3833727A (en) 1974-09-03
KE2839A (en) 1978-05-26
IL41610A (en) 1975-08-31
DE2310836B2 (de) 1976-11-04
CA1015662A (en) 1977-08-16
AU5266273A (en) 1974-08-29
FR2181786A1 (sv) 1973-12-07
BE796288A (fr) 1973-09-05
NL176746B (nl) 1985-01-02
IE37326L (en) 1973-09-06
GB1385648A (en) 1975-02-26
PH18901A (en) 1985-10-30
DD103559A5 (sv) 1974-02-05
IE37326B1 (en) 1977-06-22
ZA731505B (en) 1974-10-30
CY951A (en) 1978-12-22
IL41610A0 (en) 1973-04-30
HK23378A (en) 1978-05-12
HU165714B (sv) 1974-10-28
SE400472B (sv) 1978-04-03
DE2310836A1 (de) 1973-09-20
FR2181786B1 (sv) 1976-05-14
NL176746C (nl) 1985-06-03
MY7800295A (en) 1978-12-31
ATA195873A (de) 1975-12-15
LU67144A1 (sv) 1973-09-06

Similar Documents

Publication Publication Date Title
FR2196162A1 (sv)
FR2169126A1 (sv)
FR2181786B1 (sv)
JPS4922353A (sv)
FR2170064B1 (sv)
JPS4914034A (sv)
FR2207643B1 (sv)
FR2177121B1 (sv)
FR2181820B1 (sv)
JPS4889415U (sv)
JPS4892162A (sv)
JPS4898260U (sv)
JPS5147908Y2 (sv)
JPS551366B2 (sv)
FR2173190A1 (sv)
JPS4994934U (sv)
JPS4970062U (sv)
FR2167222A1 (sv)
JPS4888372U (sv)
JPS4967777U (sv)
CH595385A5 (sv)
CH594475A5 (sv)
CH600936A5 (sv)
CH563768A5 (sv)
CH613678A5 (sv)

Legal Events

Date Code Title Description
BC A request for examination has been filed
A85 Still pending on 85-01-01
V1 Lapsed because of non-payment of the annual fee